news of Alem's improvement is very welcome indeed.
very much so.
news of Alem's improvement is very welcome indeed.
Very well said. My early experiences relapsing and remitting and returning each time to as much work and exercise as I could are in total agreement with this. When healthy, we naturally increase our activities and fill our lives.[…] I am still bedbound now, still unable to talk, or listen to music, or watch TV. But I will do more when able to, this is a natural instinct or process and needs no intrusive input from others. It happens whenever people get over a cold or flu, I doubt there are tens of millions of people getting stuck in a vicious self-perpetuating cycle of symptoms, fear avoidance, deconditioning, and symptom focusing. It just goes against human nature […]
$28 million for research into Post-Acute Sequelae of COVID-19
Applications are open for the 2024 Post-Acute Sequelae of COVID-19 grant opportunity. Funding is from the Medical Research Future Fund (MRFF).
We are very pleased to share that Dr Christopher Armstrong and his team at Open Medicine Foundation's (OMF's) Melbourne ME/CFS Collaboration have been awarded nearly $1 million ($999,977.50) through the Medical Research Future Fund (MRFF) Post-Acute Sequelae of COVID-19 (PASC) Stream 1 grant, for the project Energy inefficiency in Long COVID and ME/CFS.
Importantly, this funding is a direct response to the Australian Government’s Long COVID Inquiry, Sick and tired: casting a long shadow. While the inquiry committed $50 million to Long COVID research, Recommendation 8 specifically called for dedicated investment in ME/CFS research, which has historically received limited Australian government funding despite now affecting an estimated 930,000 Australians.
Also:From Emerge’s Facebook:
ME/CFS Alliance Australia and co-chair Dr Mike Freelander MP invite you to attend the first, 2026 meeting of the Parliamentary Friends of ME/CFS group.
This meeting will bring together members of parliament clinicians, researchers, and people with lived experience to highlight the urgent and growing needs of Australians living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Date: Tuesday, 10 March 2026
Time: 11:00am – 1pm AEDT (May finish earlier)
Venue: Online via Zoom
Register for Zoom here - https://zurl.co/fyADw
For in-person attendance at Australian Parliament House Canberra email information@emerge.org.au as seating is limited.
Fibromyalgia ME CFS Australia Bridges & Pathways ME Advocacy Network Australia ME/CFS Australia Myalgic Encephalomyelitis Group Australia Ltd Dr Mike Freelander MP Mark Butler MP
#mecfsallianceaustralia #mecfsadvocacy #FairGoForME
A new project by researchers at the University of Tasmania’s Menzies Institute for Medical Research will deliver a care model for Long COVID that aims to improve health outcomes and enhance quality of life – while easing pressure on the healthcare system.
To ensure it can meet real-world needs, this project will be fully remote and co-designed with patients, clinicians, and health services. A large trial will evaluate its effectiveness, feasibility, and sustainability across Australia.
The project aims to reduce hospitalisations, improve quality of life, and deliver strong returns on investment for health services by maximising resource efficiency.
Key features of the project:
- Co-design and scaling: Working with patients, clinicians, and health services to adapt and refine the intervention for national rollout.
- Risk-based approach: Using a novel algorithm to identify patients most at risk of physical and cardiac dysfunction.
- Remote delivery: Making care accessible to people wherever they live.
- Rigorous evaluation: Conducting a randomised controlled trial to test effectiveness and sustainability.